Tracy Evans, MD
Dermatology · San Francisco, CANPI 1548427875
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 713 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Merz North America, Inc. at 35.8% of the total. Reporting peaked in 2019 at $5,112 and has fallen 73.7% since, to $1,343 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 713 payments — averaging $25.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$7K
- AbbVie$3K
- Pfizer$2K
- LEO Pharma Inc.$2K
- Mayne Pharma Commercial LLC$865
- Galderma Laboratories, L.p.$487
- plus $4K from 26 others
What the payments were for
- Food & beverage$18,24299%
- Education$1161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 119 | $6,581 |
| AbbVie(2 entities) | 181 | $3,147 |
| Pfizer | 79 | $1,735 |
| LEO Pharma Inc. | 105 | $1,610 |
| Mayne Pharma Commercial LLC | 73 | $865 |
| Galderma Laboratories, L.p. | 19 | $487 |
| Amgen | 14 | $375 |
| Sanofi | 7 | $348 |
| Revance Therapeutics, Inc. | 9 | $346 |
| Regeneron Healthcare Solutions, Inc. | 11 | $321 |
| Organon | 6 | $274 |
| Johnson & Johnson | 6 | $258 |
| UCB, Inc. | 13 | $253 |
| Solta Medical, A Division Of Bausch Health US, LLC | 10 | $224 |
| Novartis | 9 | $200 |
| Arcutis Biotherapeutics, Inc. | 4 | $185 |
| Incyte Corporation | 7 | $181 |
| Lilly USA, LLC | 7 | $176 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $133 |
| Sun Pharmaceutical Industries Inc. | 4 | $123 |
| Biofrontera Inc. | 5 | $101 |
| Dermira, Inc. | 4 | $87 |
| VYNE Pharmaceuticals Inc. | 3 | $67 |
| Organogenesis Inc. | 2 | $58 |
| Journey Medical Corporation | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 1 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| Tersera Therapeutics LLC | 1 | $24 |
| Almirall LLC | 1 | $23 |
| EPI Health, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,358 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 48 | $1,090 |
| Clobetasol Propionate | 15 | $1,028 |
| Minoxidil | 58 | $881 |
| ValacyclovirValacyclovir Hcl | 23 | $627 |
| Triamcinolone Acetonide | 44 | $509 |
| Cephalexin | 35 | $461 |
| Imiquimod | 16 | $283 |
| Hydrocortisone | 43 | $265 |
| Mupirocin | 26 | $191 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $60 |
| Doxycycline Hyclate | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Francisco
- Tina BhutaniSan Francisco$1.1M
- Sarina ElmariahSan Francisco$510K
- Timothy BergerSan Francisco$270K
- Marlys FassettSan Francisco$168K
- Caren CampbellSan Francisco$149K
- Kathleen WelshSan Francisco$149K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.